Aramis Biotechnologies Inc.
1 clinical trials · Sponsor
◉ Watch Aramis Biotechnologies Inc.
| Record | Firm | Date |
|---|---|---|
| Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine (NCT07291635) | Aramis Biotechnologies Inc. | 2026-02-25 |
Track Aramis Biotechnologies Inc. automatically
Every clearance here is in the API, with alerts when new ones post.